Norditropin’s Impact on Weight and Growth in American Males with Prader-Willi Syndrome
Reading Time: 3 minutes Introduction Prader-Willi Syndrome (PWS) is a complex genetic disorder characterized by a range of symptoms, including chronic feelings of hunger, obesity, reduced muscle tone, and short stature. In the United States, managing PWS presents unique challenges, particularly for males who may experience more pronounced symptoms. Norditropin, a recombinant human growth hormone, has emerged as a potential therapeutic option to address some of these challenges. This article explores a case series that examines the use of Norditropin in American males with PWS, focusing on its impact on weight management and growth. Background on Prader-Willi Syndrome and Norditropin Prader-Willi Syndrome arises from...


